A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : EORTC

Search Conditions:
Search Keyword : EORTC
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: EORTC
Appearance Frequency: 1795 time(s)
Long forms: 8

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
European Organization for Research and Treatment of Cancer
(1785 times)
Neoplasms
(936 times)
QoL (374 times)
HRQoL (172 times)
OS (97 times)
1976 EORTC randomized trial for the adjuvant therapy of T1 bladder carcinoma.
EORTC 22922-10925
(3 times)
Radiotherapy
(3 times)
LN (3 times)
DFS (2 times)
DMFS (2 times)
2013 Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials.
European Organization for Treatment and Research of Cancer
(2 times)
Neoplasms
(1 time)
HADS (1 time)
HL (1 time)
HRQoL (1 time)
2004 Depression and the use of complementary medicine among breast cancer patients.
early clinical trials group
(1 time)
Pharmacology
(1 time)
--- 1985 Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).
EORTC Quality of Life Questionnaire C30-BR23
(1 time)
Neoplasms
(1 time)
BCTOS (1 time)
QoL (1 time)
2010 Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS).
EORTC ROG and LG
(1 time)
Neoplasms
(1 time)
HR (1 time)
PCI (1 time)
SCLC (1 time)
2009 Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
European organization and cancer treatment quality of life questionnaire
(1 time)
Obstetrics
(1 time)
G-CSF (1 time)
2010 Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil).
existing prognostic models
(1 time)
Neoplasms
(1 time)
CT (1 time)
EPP (1 time)
MPM (1 time)
2014 Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales.